Literature DB >> 17374502

PU.1: a crucial and versatile player in hematopoiesis and leukemia.

Philippe Kastner1, Susan Chan.   

Abstract

Purine Rich Box-1 (PU.1)/ SFFV Proviral Integration Site-1 (Spi-1) is an Ets-family transcription factor, which was first characterized as an oncogene in Friend's murine erythroleukemia, and subsequently, as a transcriptional regulator of myeloid promoters. PU.1 has since emerged as a central regulator of all hematopoietic cell lineages. PU.1 is essential for terminal myeloid cell differentiation, B and T cell development, erythropoiesis and hematopoietic stem cell maintenance. These pleiotropic functions are reflected by its complex and dynamic expression pattern during hematopoiesis. Factors regulating this complex expression are only beginning to be revealed. Interestingly, recent work has provided strong evidence that suppression of PU.1 function is critical for the leukemic transformation of myeloid cells, both in mouse and man. Thus PU.1 is a multi-faceted protein that controls numerous normal and pathogenic functions within the hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374502     DOI: 10.1016/j.biocel.2007.01.026

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  45 in total

1.  The ancient mammalian KRAB zinc finger gene cluster on human chromosome 8q24.3 illustrates principles of C2H2 zinc finger evolution associated with unique expression profiles in human tissues.

Authors:  Peter Lorenz; Sabine Dietmann; Thomas Wilhelm; Dirk Koczan; Sandra Autran; Sophie Gad; Gaiping Wen; Guohui Ding; Yixue Li; Marie-Françoise Rousseau-Merck; Hans-Juergen Thiesen
Journal:  BMC Genomics       Date:  2010-03-26       Impact factor: 3.969

Review 2.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

3.  Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension.

Authors:  Kandarp H Shah; Peng Shi; Jorge F Giani; Tea Janjulia; Ellen A Bernstein; You Li; Tuantuan Zhao; David G Harrison; Kenneth E Bernstein; Xiao Z Shen
Journal:  Circ Res       Date:  2015-08-20       Impact factor: 17.367

4.  A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.

Authors:  Silvia Grassilli; Ervin Nika; Elisabetta Lambertini; Federica Brugnoli; Roberta Piva; Silvano Capitani; Valeria Bertagnolo
Journal:  Cell Oncol (Dordr)       Date:  2016-08-01       Impact factor: 6.730

5.  PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells.

Authors:  Kevin S Choe; Olga Ujhelly; Sandeep N Wontakal; Arthur I Skoultchi
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

6.  miR-155 drives oncogenesis by promoting and cooperating with mutations in the c-Kit oncogene.

Authors:  Lisa W Witten; Christopher J Cheng; Frank J Slack
Journal:  Oncogene       Date:  2018-11-20       Impact factor: 9.867

Review 7.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

8.  HOXA9 regulates miR-155 in hematopoietic cells.

Authors:  Yu-Long Hu; Stephen Fong; Corey Largman; Wei-Fang Shen
Journal:  Nucleic Acids Res       Date:  2010-05-05       Impact factor: 16.971

Review 9.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

10.  Targeted resequencing and analysis of the Diamond-Blackfan anemia disease locus RPS19.

Authors:  Alvaro Martinez Barrio; Oskar Eriksson; Jitendra Badhai; Anne-Sophie Fröjmark; Erik Bongcam-Rudloff; Niklas Dahl; Jens Schuster
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.